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Abstract: 
Introduction: 
Cocaine-induced midline destructive lesions (CIMDL) are complications of regular nasal cocaine 
inhalation. CIMDL can mimic systemic diseases with positive anti-neutrophil cytoplasmic antibodies 
(ANCA), such as granulomatosis with polyangiitis (GPA). 
 
Case Report: 
In this article, we describe the case of a young woman who presented with nasal perforation induced 
by cocaine, along with positive perinuclear ANCA test (proteinase 3 antigen), misdiagnosed as 
limited GPA. The patient was treated with immunosuppressive therapy, which partially improved her 
symptoms. Admittance of cocaine use aided in the diagnosis of CIMDL. This patient was advised to 
stop cocaine use. Three-month follow-up revealed no further complications. 
 
Conclusion: 
Considering the seropositivity of ANCA in both CIMDL and GPA, early diagnosis of CIMDL and its 
differentiation from GPA is crucial, and clinicians play an important role in this regard. Lack of 
distinct histologic characteristics of vasculitis or unresponsiveness to standard therapeutic regimens 
may favor the diagnosis of CIMDL syndrome. It is crucial to recognize that these conditions may 
have similar presentations, so that undesired and potentially toxic treatments can be prevented. 
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Introduction 
The prevalence of cocaine use is growing 
worldwide (1,2). However, due to its high 
price, it is not a widely used recreational drug 
in third-world countries, and as a result, its 
complications are usually difficult to 
distinguish from other diseases in those 
countries because its use is rare. Also, 
presentation to a healthcare professional is rare 
due to significant cultural taboos and fear of 
rejection. 
Nasal and paranasal tissue damage and 
necrosis are sequelae of frequent and regular 
cocaine nasal inhalation. This frequent 
inhalation may result in an inflamed and 
ulcerated nasal mucosa and perforated septum. 
This complication is termed “cocaine-induced 
midline destructive lesion (CIMDL)” (1,3). 
Prevalence of CIMDL is 4.8% among cocaine 
users (4). CIMDL mimics the clinical 
manifestations of systemic diseases with 
positive anti-neutrophil cytoplasmic antibodies 
(ANCA), such as small-vessel vasculitis, 
including granulomatosis with polyangiitis 
(GPA) (5-7). Interestingly, ANCA has been 
detected in a significant number of CIMDL 
cases in which clinical presentation of lesions 
was indistinguishable from GPA limited to the 
upper respiratory tract (5,8,9). 
The pathogenesis of CIMDL is largely 
unknown, but inflammatory, infective, pro-
apoptotic and autoimmune mechanisms have 
been implicated (4). One hypothesis is that 
longstanding cocaine usage could cause 
mucosa and perichondrium progressive 
destruction via a direct vasoconstrictor impact 
(2,10). Necrotic septal cartilage due to 
ischemia and septal perforation, which 
resembles the upper airway clinical pictures of 
GPA, would thus ensue. 
Differentiating CIMDL from limited GPA is 
challenging, especially when the clinical 
history of cocaine abuse is vague and its use is 
not common. 
Here we describe the case of a young lady in 
Iran who presented with cocaine-induced nasal 
perforation and positive ANCA test, primarily 
misdiagnosed as ANCA-associated vasculitis 
because of the patient’s denial of substance 
dependence. 
 
Case Report 
A 30-year-old woman was referred to our 
clinic with a 2-month history of epistaxis and 
necrotizing lesions of her nose with a 
background of chronic sinusitis and 
rhinorrhea. Ear, nose, and throat (ENT) 
examination of the patient indicated a defect in 
her nasal septum. 
The coronal and axial cut of computed 
tomography (CT) reconstructions of nasal soft 
tissues and paranasal sinuses revealed mucosal 
thickening in the right maxillary sinus and a 
defect in the anterior aspect of the nasal septum 
with an approximate diameter of 13 mm (Fig.1). 
The nasal septum biopsy revealed respiratory 
mucosa with ulceration, acute inflammation, and 
granulation tissue formation (Fig.2). 
 
Fig1: CT scan of sinus revealing a thickness in the 
right maxillary sinus and a defect in the anterior 
aspect of the nasal septum. 
 
Fig2: Histopathology slides of the nasal biopsy 
specimens revealed ulceration of the epithelium 
with granulation tissue formation. (A) Severe 
infiltration of mixed inflammatory cells in 
submucosa with infiltration into vascular wall 
(arrow) (x200). (B)Ulceration of nasal mucosa 
(arrow) associated with fibrin exudate material and 
severe mixed inflammation of submucosa (x200). 
Kidney function and chest X-ray were normal. 
Laboratory findings were leukocyte count 
13,600 per μl (normal range 4,500 to 11,000), 
which was mildly elevated; hemoglobin 13 
g/dl; platelets 373,000/mm³; high erythrocyte 
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sedimentation rate (ESR) 35 mm/h (normal 
range up to 20); elevated C-reactive protein 
(CRP) 45 mg/L (normal range up to 6); 
perinuclear ANCA (p-ANCA) 1/320 (normal 
range up to 1/10) with positive antigen-specific 
ANCA directed against proteinase 3 (PR3) and 
negative myeloperoxidase (MPO), cytoplasmic 
ANCA (c-ANCA), antinuclear antibody (ANA) 
and rheumatoid factor. All tests for HIV virus, 
hepatitis C and hepatitis B viruses, FTA-ABS 
and venereal disease research laboratory 
(VDRL) were negative. Purified protein 
derivative (PPD) test was not reactive. 
Leishmaniasis and blastomycosis serology were 
also negative. 
When asked, the patient denied being a drug 
abuser. Thus, the combination of clinical, 
serologic and histologic findings, including 
ulceration, inflammation, and granulation 
tissue formation (Fig.2) led to the diagnosis of 
ANCA-associated vasculitis, most likely 
limited GPA. 
Her treatment with prednisolone (50 mg/day), 
sulfamethoxazole and trimethoprim was started, 
followed by adding methotrexate (15 
mg/week). After 3 months, with no evidence of 
improvement clinically or serologically, and 
considerable weight gain due to the high-dose 
steroid, rituximab was administered to the 
patient, but with only a minor improvement in 
the symptoms. At this point, the patient 
admitted the ongoing nasal use of cocaine. 
Subsequently, the causative effect of cocaine 
was suspected, and the patient was advised to 
stop cocaine abuse. During 3 months of further 
clinical follow-ups, no additional new problems 
related to CIMDL were identified. Written 
informed consent was obtained from the patient 
in order to publish her case. 
 
Discussion 
We are witnessing a remarkable rise in 
cocaine use worldwide at this time. 
Consequently, destructive mid-facial lesions 
caused by CIMDL, mimicking the clinical 
picture of other diseases, is likely to become a 
more common scenario (1,2). Nonetheless, 
because of the high price of cocaine, it is still 
not commonly in use among drug users in 
low-socioeconomic areas of the world. 
Overlap of clinical signs and symptoms means 
that complications with this drug can be easily 
misdiagnosed with those of other diseases.  
 As a result, the positive result of the ANCA 
test makes the differentiation of this condition 
from middle- and small-vessel vasculitis, such 
as limited GPA, more challenging. 
Nasal involvement is frequently seen in many 
rheumatologic illnesses. These signs are 
helpful to establish a diagnosis. Therefore, 
these patients’ assessments and investigations 
should include a multidisciplinary approach, 
such as a rigorous history and thorough 
clinical examination. 
A study by Armengot et al. elucidated that 
GPA has the highest level of sinonasal 
involvement among the systemic vacuities (6). 
GPA is a systemic disease characterized by 
granulomatous inflammation and necrosis of 
the upper and lower respiratory tract, a 
vasculitis which is mainly noted in small- and 
medium-size vessels, with focal segmental or 
proliferative glomerulosclerosis (11).GPA can 
present at any age; however, it is most 
prevalent around the age of 40 (6). It is 
interesting to note that, as in our case, the 
majority of previous cases of CIMDL were in 
women from a relatively young age group 
(10). This could suggest that female users may 
be more susceptible to the nasal complications. 
Nasal manifestations are the presenting signs 
in around 50–90% of GPA cases (12), and 
ANCAs are present in up to 83% of cases of 
limited GPA (13). It is of particular note that 
according to the study by Wiesner et al., 84% 
of the CIMDL patients were found to have a 
positive ANCA test (9). A distinct p-ANCA 
pattern targeting elastase or other nonspecific 
antigens are shown in CIMDL (14). All these 
findings together could potentially complicate 
making a differential diagnosis. 
Although the precise pathophysiology of 
ANCA abnormalities is not completely known, 
ANCA positivity could be correlated with the 
presence of Staph aureus. It has been revealed 
that Staph aureus nasal carriers are linked with 
greater rates of relapse in GPA (15). A 
significant number of CIMDL patients are also 
carrying Staph aureus in their nose and cultures 
of nasal tissue grow Staph aureus (2,16). 
As mentioned above, cocaine-associated 
mucosal destruction is multifactorial. Focal 
mucosal vasoconstriction is believed to play a 
leading role (2-4,10). Furthermore, although 
invasive fungal rhinosinusitis may be a serious 
complication of intranasal cocaine abuse (2),  
Mirzaei A, et al 
312  Iranian Journal of Otorhinolaryngology, Vol.30(5), Serial No.100, Sep2018 
it was not detected in this patient. It is 
imperative to diagnose correctly whether the 
lesions stem from autoimmune vasculitis or 
cocaine abuse, because the management plans 
and clinical pathways are different (6). 
Clinical, analytical, and histopathological 
findings can distinguish between these two 
conditions (6). 
Spontaneously resolving epistaxis, rhinorrhea, 
and scabs are the most common symptoms, as 
were also seen in this patient (10,12). 
Differentiation of these manifestations from 
typical GPA is not always easy. In CIMDL, the 
sinonasal region is mostly affected without the 
involvement of the other parts (1).
 
Histopathologically, while acute inflammatory 
and chronic perivascular infiltrates are seen in a 
few CIMDL patients, the salient feature of this 
condition is extensive necrosis. GPA-associated 
features (granulomas, giant multinucleated 
cells, leukocytoclasia, or fibrinoid changes) are 
rarely observed in CIMDL (2). Granulation 
tissue formation along with no typical 
granuloma, as seen in our case, could help the 
correct diagnosis of similar cases. 
 
Another form of the cocaine-induced 
syndrome is levamisole-induced vasculitis. In 
total, 70% of the available batches of cocaine 
are contaminated with levamisole (4), which is 
currently used as a veterinary anthelmintic 
medication and appears to be a ubiquitous 
adulterant associated with cocaine abuse (17).  
This condition has a diverse range of auto-
immunoglobulin findings, including p-ANCA 
and c-ANCA. The probable mechanism of 
ANCA positivity in CIMDL could be nasal 
carriage of Staph aureus that can trigger the 
autoimmune system (15). The fact that around 
70% of cocaine is contaminated with 
levamisole may also partly account for the 
ANCA positivity in this syndrome (7). 
Considering its more systemic manifestations 
compared with CIMDL, its differentiation 
from autoimmune conditions like GPA and 
other small-vessel vasculitis might be even 
more challenging (18). While we did not have 
any evidence of levamisole-adulterated 
cocaine use in our case, when treating a patient 
with features of systemic vasculitis resistant to 
treatment, it would be worth checking whether 
the cocaine used by the patient contains 
levamisole. The optimal therapy for CIMDL 
is aggressive immunosuppressive therapy, 
including corticosteroid, cyclophosphamide, 
mycophenole mofetil, and methotrexate, which 
are options in those with the substantial 
inflammatory disease, or in cases showing no 
improvement following the cessation of cocaine 
use (1). 
Awareness of ANCA positivity along with 
clinical manifestations similar to vasculitis in 
CIMDL could lead to a correct diagnosis of 
CIMDL, especially in regions with lower use or 
availability of cocaine. 
In our case, the presence of 1) a nasal defect 
along with ulceration of the epithelium with 
granulation tissue formation; 2) severe 
infiltration of mixed inflammatory cells in 
submucosa with infiltration into vascular wall 
in histopathologic examination; 3) the positive 
ANCA test (confirmed by both ELISA and 
indirect immunofluorescence methods), and 4) 
elevated inflammatory markers, led to the 
misdiagnosis of ANCA-associated vasculitis. In 
addition to these, the patient’s denial of drug 
abuse with cocaine contributed to the clinicians’ 
wrong identification of the underlying cause of 
the clinical and para-clinical features. 
A urine test in cases of suspected cocaine 
abuse may be a useful tool to determine 
whether these clinical manifestations and 
treatment failure are in keeping with ongoing 
cocaine abuse. Benzoylecgonine is a cocaine 
metabolite, which can be detected in urine for 2 
weeks following use (19). 
 
Conclusion 
Differentiation between ANCA-associated 
primary vasculitis and CIMDL is challenging. 
This is due to their similar clinical, serological, 
and histological manifestations. Despite the 
similarities of CIMDL with diseases like 
Wegener's granulomatosis, the presence of nasal 
septum defect, the lack of distinct vasculitis 
histologic findings, and unresponsiveness to 
standard therapeutic regimen may favor the 
diagnosis of CIMDL syndrome. In order to 
avoid unnecessary harmful immunosuppressant 
therapy, a thorough history-taking and 
exploration of intranasal insufflations of cocaine 
play an important role in differentiating these 
conditions. While immunosuppressive therapy is 
likely to help in the management of this 
condition and to limit the progressive damage, 
stopping cocaine abuse is the mainstay of 
treatment. 
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